apoptotic responsiveness of CLL B cells to fludarabine, as a basis for ultimately linking these with clinical outcome.-augmented signaling.This linkage in CLL B cells among the mechanisms governing chemotherapy-induced apoptosis increased signaling of BCR network proteins and a likely role of phosphatase activity suggests a means of stratifying patients for their response to F-ara-A based regimens. Future studies will examine the clinical applicability of these findings and also the utility of this approach in relating mechanism to function of therapeutic agents
Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course that reflects biologi...
The levels of tumour necrosis factor receptor (TNF-R) superfamily members can be altered in lymphoid...
Chronic lymphocytic leukemia (CLL) has a high incidence and a steeply growing prevalence in the West...
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a B cell malignancy with a variable clinical cours...
Fludarabine (F-ara-A), an adenine nucleoside analog with efficacy in B-cell chronic lymphocytic leuk...
B-cell chronic lymphocytic leukaemia (B-CLL) is a clinically heterogeneous disease characterised by ...
The expression of P53, Bcl-2, Bax, Bag-1, and Mcl-1 proteins in CD5/CD20-positive B-chronic lymphocy...
B cell chronic lymphocytic leukaemia (B-CLL) is the most common adult leukaemia in the western world...
B-cell chronic lymphocytic leukemia (B-CLL), characterized by an accumulation of monclonal B cells, ...
BACKGROUND AND OBJECTIVES: In chronic lymphocytic leukemia (CLL) B-cells are refractory to activatio...
The B cell receptor (BCR) is a master regulator of B cells, controlling cellular processes such as p...
Background. Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course, with som...
Chronic lymphocytic leukemia (CLL) is an incurable disease characterized by the accumulation of term...
Chronic lymphocytic leukaemia (CLL) is the commonest haematological malignancy in the western world ...
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy. High levels of Bcl-2 and IAP family prote...
Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course that reflects biologi...
The levels of tumour necrosis factor receptor (TNF-R) superfamily members can be altered in lymphoid...
Chronic lymphocytic leukemia (CLL) has a high incidence and a steeply growing prevalence in the West...
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a B cell malignancy with a variable clinical cours...
Fludarabine (F-ara-A), an adenine nucleoside analog with efficacy in B-cell chronic lymphocytic leuk...
B-cell chronic lymphocytic leukaemia (B-CLL) is a clinically heterogeneous disease characterised by ...
The expression of P53, Bcl-2, Bax, Bag-1, and Mcl-1 proteins in CD5/CD20-positive B-chronic lymphocy...
B cell chronic lymphocytic leukaemia (B-CLL) is the most common adult leukaemia in the western world...
B-cell chronic lymphocytic leukemia (B-CLL), characterized by an accumulation of monclonal B cells, ...
BACKGROUND AND OBJECTIVES: In chronic lymphocytic leukemia (CLL) B-cells are refractory to activatio...
The B cell receptor (BCR) is a master regulator of B cells, controlling cellular processes such as p...
Background. Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course, with som...
Chronic lymphocytic leukemia (CLL) is an incurable disease characterized by the accumulation of term...
Chronic lymphocytic leukaemia (CLL) is the commonest haematological malignancy in the western world ...
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy. High levels of Bcl-2 and IAP family prote...
Chronic lymphocytic leukemia (CLL) patients exhibit a variable clinical course that reflects biologi...
The levels of tumour necrosis factor receptor (TNF-R) superfamily members can be altered in lymphoid...
Chronic lymphocytic leukemia (CLL) has a high incidence and a steeply growing prevalence in the West...